117 related articles for article (PubMed ID: 16042058)
1. [Micrometastases in patients with colorectal cancer: markers for metastatic potential or proofs for residual disease].
Iovchev I; Trifonov D; Popkharitov A; Khadzhipetkov F; Nikolov S
Khirurgiia (Sofiia); 2004; 60(4-5):18-21. PubMed ID: 16042058
[TBL] [Abstract][Full Text] [Related]
2. [Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients].
Leinung S; Schönfelder A; Schönfelder M
Zentralbl Chir; 1998; 123(5):520-4. PubMed ID: 22462221
[TBL] [Abstract][Full Text] [Related]
3. Micrometastases: marker of metastatic potential or evidence of residual disease?
O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
[TBL] [Abstract][Full Text] [Related]
4. The impact of bone marrow micrometastases on metastatic disease-free survival in patients with colorectal carcinoma.
O'Connor OJ; Cahill RA; Kirwan WO; Redmond HP
Colorectal Dis; 2005 Jul; 7(4):406-9. PubMed ID: 15932568
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
[TBL] [Abstract][Full Text] [Related]
7. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Bjørnland K; Flatmark K; Mala T; Mathisen O; Bakka A; Aasen AO; Bergan A; Søreide O; Fodstad O
J Surg Oncol; 2003 Apr; 82(4):224-7. PubMed ID: 12672004
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
9. Micrometastases in bone marrow of patients with suspected pancreatic and ampullary cancer.
van Heek NT; Tascilar M; van Beekveld JL; Drillenburg P; Offerhaus GJ; Gouma DJ
Eur J Surg Oncol; 2001 Dec; 27(8):740-5. PubMed ID: 11735170
[TBL] [Abstract][Full Text] [Related]
10. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
Thorban S; Roder JD; Pantel K; Siewert JR
Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
[TBL] [Abstract][Full Text] [Related]
11. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Weihrauch MR; Skibowski E; Koslowsky TC; Voiss W; Re D; Kuhn-Regnier F; Bannwarth C; Siedek M; Diehl V; Bohlen H
J Clin Oncol; 2002 Nov; 20(21):4338-43. PubMed ID: 12409333
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
14. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
15. Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment.
Cotta CV; Konoplev S; Medeiros LJ; Bueso-Ramos CE
Ann Diagn Pathol; 2006 Jun; 10(3):169-92. PubMed ID: 16730315
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of cytokeratin-positive cells in the bone marrows of colorectal carcinoma patients.
Shetye JD; Liljefors ML; Emdin SO; Frödin JE; Strigård K; Mellstedt HT; Porwit A
Anticancer Res; 2004; 24(4):2375-83. PubMed ID: 15330187
[TBL] [Abstract][Full Text] [Related]
17. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
18. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
20. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
